Title: Hammond’s Candies Recalls Chocolate Products Over Undeclared Milk Concerns
Introduction:
Hammond’s Candies, a Colorado-based company, has issued a recall for its Dark Chocolate Filled Mini Waffle Cones due to potential undeclared milk in the product. Allergic individuals could experience serious or life-threatening reactions if they consume these items. This recall comes after a consumer reported an allergic reaction, prompting the company to investigate further. The U.S. Food and Drug Administration (FDA) reposted the recall notice on September 6, urging consumers to take immediate action.
Undeclared Milk Recall:
Hammond’s Candies has voluntarily recalled 4-ounce bags of Dark Chocolate Filled Mini Waffle Cones. The company discovered that these products contain more than trace amounts of milk proteins, despite not indicating it on the packaging. Individuals with milk allergies or severe sensitivity are at risk of experiencing severe allergic reactions if they consume these products. The stand-up, resealable bags have product code LN0525453 and “Use By” dates of March 20, 2025, and May 20, 2025. These waffle cones were distributed across 39 states through retail stores, Amazon, and the company’s website.
Actions to Take:
Consumers who have purchased the affected items are advised to return them to the place of purchase for a full refund. Alternatively, they can contact the company directly for assistance. Prompt action is crucial to ensure the safety of individuals with milk allergies and prevent potential allergic reactions.
Recent Product Recalls:
Hammond’s Candies’ recall is part of a series of recent product withdrawals due to undeclared milk. On August 29, NY-based M&P Food Production recalled various flavors of blintzes, pirozhki, and vareniki for containing undeclared milk, wheat, and/or sesame. An FDA inspection revealed that these ingredients were not clearly disclosed on the package. Similarly, on August 21, Unilever recalled approximately 137,000 cases of Popsicle Jolly Rancher Frozen Confection Pop products due to undisclosed milk. Too Good Gourmet also recalled chocolate chip cookie products earlier that month for similar concerns.
Understanding Milk Allergies:
According to the American College of Allergy, Asthma & Immunology (ACAAI), approximately two to three percent of children under the age of three are allergic to milk. However, around 80 percent of these children are likely to outgrow the allergy before turning 16. Symptoms of milk allergy include stomach upset, vomiting, and blood in stools, particularly in infants. Severe cases can result in anaphylaxis, a life-threatening condition that affects breathing and can send the body into shock. The ACAAI emphasizes that strict avoidance of milk and milk-containing products is the only way to manage this allergy.
Labeling Requirements and Medication:
The ACAAI highlights that milk is one of the eight allergens with mandatory labeling requirements. Food businesses using milk as an ingredient must clearly list it on product labels. In February, the FDA approved Xolair, the first medication in the country to help reduce allergic reactions triggered by accidental exposure to multiple foods, including milk. Clinical trials showed promising results, with 66 percent of subjects who took Xolair able to consume significant amounts of milk without experiencing moderate to severe allergic symptoms. However, Xolair carries potential side effects, including fever and injection site reactions, and comes with a boxed warning for anaphylaxis.
Conclusion:
Hammond’s Candies has taken immediate action by recalling its Dark Chocolate Filled Mini Waffle Cones due to undeclared milk concerns. This recall serves as a reminder of the importance of accurate labeling for individuals with milk allergies. Consumers are urged to check product labels carefully and promptly return any affected items for a refund. The ACAAI emphasizes the need for strict avoidance of milk and milk-containing products for those with milk allergies, while highlighting the recent FDA-approved medication, Xolair, as a potential option to reduce allergic reactions.
